Literature DB >> 20682439

Getting to the heart of the matter: direct reprogramming to cardiomyocytes.

Robert Passier1, Christine Mummery.   

Abstract

Since MyoD was used to convert fibroblasts directly to skeletal muscle, biologists have tried to apply this strategy to generate other cell lineages. In their recent Cell paper, Ieda et al. (2010) use selected cardiac transcription factors to directly reprogram fibroblasts to cardiomyocytes without passing through an intervening pluripotent state. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID： 20682439     DOI： 10.1016/j.stem.2010.07.004

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  8 in total

1.  Perspective for special Gurdon issue for differentiation: can cell fusion inform nuclear reprogramming?

Authors:  David Burns; Helen M Blau
Journal:  Differentiation       Date:  2014-08-21       Impact factor: 3.880

2.  Cardiac cell therapy: the next (re)generation.

Authors:  Elvira Forte; Isotta Chimenti; Lucio Barile; Roberto Gaetani; Francesco Angelini; Vittoria Ionta; Elisa Messina; Alessandro Giacomello
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

3.  Somatic Cell Reprogramming into Cardiovascular Lineages.

Authors:  Jenny X Chen; Karolina Plonowska; Sean M Wu
Journal:  J Cardiovasc Pharmacol Ther       Date:  2014-04-23       Impact factor: 2.457

Review 4.  Present state and future perspectives of using pluripotent stem cells in toxicology research.

Authors:  Anna M Wobus; Peter Löser
Journal:  Arch Toxicol       Date:  2011-01-12       Impact factor: 5.153

5.  Control of Stochastic and Induced Switching in Biophysical Networks.

Authors:  Daniel K Wells; William L Kath; Adilson E Motter
Journal:  Phys Rev X       Date:  2015-09-16       Impact factor: 15.762

Review 6.  Direct reprogramming of fibroblasts into cardiomyocytes.

Authors:  Yueqiu Chen; Ziying Yang; Zhen-Ao Zhao; Zhenya Shen
Journal:  Stem Cell Res Ther       Date:  2017-05-25       Impact factor: 6.832

7.  In vivo combinatory gene therapy synergistically promotes cardiac function and vascular regeneration following myocardial infarction.

Authors:  Sunghun Lee; Bong-Woo Park; Yong Jin Lee; Kiwon Ban; Hun-Jun Park
Journal:  J Tissue Eng       Date:  2020-09-04       Impact factor: 7.813

8.  In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor.

Authors:  Megumi Mathison; Robert P Gersch; Ahmed Nasser; Sarit Lilo; Mallory Korman; Mitchell Fourman; Neil Hackett; Kenneth Shroyer; Jianchang Yang; Yupo Ma; Ronald G Crystal; Todd K Rosengart
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.